In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ascendis Pharma (ASND – Research ...

Ascendis Pharma A/S announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary ...

Ascendis Pharma will license its TransCon technology to Novo to develop therapies for metabolic and cardiovascular diseases.

Novo Nordisk ( NVO, Financials) entered an exclusive agreement with Ascendis Pharma ( ASND, Financials) to license Ascendis's TransCon technology platform for developing novel treatments targeting ...

GLP-1 agonist Wegovy (semaglutide) brought in DKK 17.3 billion ($2.49 billion) in the period, restoring earlier levels of ...

Investors are always looking for stocks that are poised to beat at earnings season and Ascendis Pharma (NASDAQ:ASND) A/S ASND may be one such company. The firm has ...

In a report released today, Peter Welford from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report), with a price ...

Tens of thousands of U.S. citizens live in the Israeli-occupied territory, on opposing sides of an entrenched conflict, where neither Palestinians nor Israelis have much enthusiasm for Kamala ...

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 27,123.90 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...

Three gangsters entered a West Delhi showroom in broad daylight yesterday, gave the owner an extortion note with an amount written on it, fired multiple times in the air to drive home their ...

At least two polling sites in the US election battleground state of Georgia were briefly evacuated on Tuesday after fake bomb threats that election officials in the state blamed on Russian agents.